A Silicon Valley-based startup formerly known as Ciitizen relaunched as Citizen Health on Tuesday — as well as announced a $14.5 million seed funding round led by Transformation Capital and a new partnership with…
Continue Reading
Citizen Health, a company that helps patients oversee rare and complex health conditions, announced it raised $14.5 million in seed funding.Transformation Capital led the round with participation from Wavemaker 360 and prominent angel investors.
The…
What You Should Know:
– Citizen Health, an innovative AI-powered consumer health platform designed to support over 400 million individuals managing rare and complex conditions, has announced the successful closing of a $14.5 million seed round.
– The…
Continue Reading
Environmental factors amplified by climate change contribute significantly to the global burden of disease, disproportionately impacting vulnerable populations, such as individuals with rare diseases. Researchers require innovative, dynamic data linkage methods to enable the…
Continue Reading
Consortium to advocate for safe AI, genomics useA consortium pushing for the safe use of advanced analytics for enhanced genetic disease diagnosis will be established with the assistance of federal government funding.
The Centre for Population Genomics,…
The new funding from Amazon Web Services, the Children’s Health Innovation Award or Imagine grant, provides $7 million for cloud-based data resources for pediatric research, maternal child total health and empowering pediatric workforces and…
Continue Reading
What You Should Know:
– Today Truveta announced the availability of expanded concepts from clinical notes — including family history, medication details reported to providers, and complex concepts for a wide range of therapeutic areas…
Continue Reading
TeleRare Health announced its launch to offer virtual care appointments for individuals with rare diseases, focusing on diagnosis, disease assessment and ongoing care. The platform connects patients with expert clinicians and offers molecular diagnostics as…
Continue Reading
What You Should Know:
– Invitae (NYSE: NVTA), a medical genetics company, announced the completion of its sale of certain reproductive health assets, including carrier screening and non-invasive prenatal screening (NIPS), to Natera (NASDAQ: NTRA).
–…
Continue Reading
Advancements in AI-driven healthcare and pharmaceuticals are reshaping the industry, evident through recent funding and collaborations. Peptris Technologies, backed by $1 million, expands AI drug discovery to rare diseases. Cipla boosts its stake in…
Continue Reading
